Low Hemoglobin: Why Anemia Happens and How to Raise It Back to Normal

Anemia — below-normal hemoglobin concentration — affects approximately 1.6 billion people globally according to WHO estimates. It is the most prevalent nutritional condition in the world, and its consequences (fatigue, reduced cognitive function, impaired exercise capacity, increased maternal and infant mortality in severe cases) are widely underappreciated because the condition is often sub-symptomatic until significant.

The treatment depends entirely on the cause. Supplementing iron for B12-deficiency anemia does nothing; treating B12 deficiency with iron does nothing. The diagnostic work-up determines causation; the treatment follows.

The Erythropoiesis Framework

Red blood cells (erythrocytes) are produced in the bone marrow from stem cells, under stimulation by erythropoietin (EPO, produced in the kidney in response to tissue hypoxia). A mature erythrocyte lives approximately 120 days, then is cleared by the spleen.

Anemia results from:

• 1. Reduced production: Insufficient raw materials (iron, B12, folate), insufficient EPO signal (kidney disease), bone marrow suppression (chemotherapy, aplastic anemia)
• 2. Increased destruction: Hemolysis (immune-mediated, mechanical, or hereditary causes)
• 3. Loss: Hemorrhage (acute or chronic occult blood loss)

Iron Deficiency Anemia (IDA)

The most common cause worldwide (accounts for approximately 50% of all anemia). Iron is required for hemoglobin synthesis (each hemoglobin molecule contains 4 iron atoms). Iron deficiency proceeds in stages:

• 1. Iron depletion: Ferritin falls below normal range, but hemoglobin is still maintained (iron mobilized from stores)
• 2. Iron-deficient erythropoiesis: Raw material shortage reduces hemoglobin production per erythrocyte
• 3. Iron deficiency anemia: Hemoglobin falls below normal threshold (12 g/dL in women, 13 g/dL in men)

Laboratory signature: low hemoglobin + low MCV (microcytic, hypochromic erythrocytes) + low ferritin + low serum iron + high TIBC.

Treatment: Correct the cause of iron depletion AND replete iron stores. Common cause: inadequate dietary iron, chronic blood loss (heavy menstruation, GI blood loss — testing for GI malignancy is indicated in post-menopausal women and men with IDA). Supplemental iron: ferrous sulfate 150–200mg elemental iron per day in 2–3 divided doses; ferrous bisglycinate if GI intolerance.

> 📌 WHO recommends 120mg elemental iron per day for 3 months for treatment of iron deficiency anemia; replenishment typically requires 2–6 months of supplementation after hemoglobin normalization to rebuild ferritin stores. [1]

Vitamin B12 and Folate Deficiency

B12 and folate are both required for DNA synthesis in rapidly dividing cells, including erythrocyte precursors. Deficiency produces megaloblastic anemia: erythrocyte precursors cannot divide properly, producing large (macrocytic, high MCV) erythrocytes that are functionally inferior.

Laboratory signature: high MCV + low B12 or folate + hypersegmented neutrophils on blood smear.

B12-specific features: B12 is obtained only from animal products (meat, fish, dairy, eggs). Strict vegetarians and vegans are at risk without supplementation. B12 absorption requires intrinsic factor (gastric protein) — autoimmune destruction of intrinsic factor-producing parietal cells causes pernicious anemia, requiring intramuscular or high-dose oral B12.

Folate deficiency causes are typically dietary (low vegetable consumption) or increased demand (pregnancy — why folate supplementation is standard in pregnancy).

---

Key Terms

• Ferritin — the primary iron storage protein; measured in serum; the most sensitive marker of iron depletion, falling before hemoglobin declines; below 30 ng/mL indicates iron depletion; below 12 ng/mL indicates severe iron deficiency
• MCV (Mean Corpuscular Volume) — the average size of red blood cells; low MCV (microcytosis) indicates iron deficiency anemia; high MCV (macrocytosis) indicates B12 or folate deficiency megaloblastic anemia; the key differential variable in anemia type classification
• Intrinsic factor — the gastric protein secreted by parietal cells required for B12 absorption in the terminal ileum; absent in pernicious anemia (autoimmune parietal cell destruction); its absence requires bypassing gut absorption via intramuscular B12 injection or supraphysiological oral doses
• Erythropoietin (EPO) — the kidney-produced hormone that stimulates bone marrow erythrocyte production in response to tissue hypoxia; used therapeutically in kidney disease–associated anemia and inappropriately in athletics (blood doping)

---

Scientific Sources

• 1. WHO. (2011). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva. Available at WHO.